Neuregulin 1-induced AKT and ERK phosphorylation in patients with fragile X syndrome (FXS) and intellectual disability associated with obstetric complications. (Q54375474)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 February 2014

Language	Label	Description	Also known as
English	Neuregulin 1-induced AKT and ERK phosphorylation in patients with fragile X syndrome (FXS) and intellectual disability associated with obstetric complications.	scientific article published on 23 February 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24563264%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Neuregulin 1-induced AKT and ERK phosphorylation in patients with fragile X syndrome (FXS) and intellectual disability associated with obstetric complications (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24563264%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

phosphorylation

1 reference

based on heuristic

inferred from title

fragile X syndrome

1 reference

based on heuristic

inferred from title

disability affecting intellectual abilities

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24563264%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Tamás Kovács

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24563264%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Boglárka Bánsági

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24563264%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Szabolcs Kéri

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24563264%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

23 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24563264%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Journal of Molecular Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24563264%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24563264%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24563264%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

119-124

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24563264%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Early myoclonic encephalopathy caused by a disruption of the neuregulin-1 receptor ErbB4

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

The neuregulin-I/ErbB signaling system in development and disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Regulation of molecular pathways in the Fragile X Syndrome: insights into Autism Spectrum Disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

The role of fragile X mental retardation protein in major mental disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Fragile X mental retardation protein levels are decreased in major psychiatric disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

mRNA and protein expression for novel GABAA receptors θ and ρ2 are altered in schizophrenia and mood disorders; relevance to FMRP-mGluR5 signaling pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Lack of association between mutation size and cognitive/behavior deficits in fragile X males: a brief report

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Drug discovery for autism spectrum disorder: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

The fragile X-associated disorders: time to order fragile X DNA testing.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Downregulation of GABA(A) β subunits is transcriptionally controlled by Fmr1p

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Cellular stress-induced up-regulation of FMRP promotes cell survival by modulating PI3K-Akt phosphorylation cascades

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Positive feedback regulation of Akt-FMRP pathway protects neurons from cell death

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Neuregulin-1 regulates cell adhesion via an ErbB2/phosphoinositide-3 kinase/Akt-dependent pathway: potential implications for schizophrenia and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Contrast, motion, perceptual integration, and neurocognition in schizophrenia: the role of fragile-X related mechanisms.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Neuregulin 1-stimulated phosphorylation of AKT in psychotic disorders and its relationship with neurocognitive functions.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Suppression of the P50 evoked response and neuregulin 1-induced AKT phosphorylation in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

The relationship among neuregulin 1-stimulated phosphorylation of AKT, psychosis proneness, and habituation of arousal in nonclinical individuals

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Decreased fragile X mental retardation protein (FMRP) is associated with lower IQ and earlier illness onset in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Toward Fulfilling the Promise of Molecular Medicine in Fragile X Syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

An old method facing a new challenge: re-visiting housekeeping proteins as internal reference control for neuroscience research

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Investigating the relationship between FMR1 allele length and cognitive ability in children: a subtle effect of the normal allele range on the normal ability range?

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Deletion of PTEN produces deficits in conditioned fear and increases fragile X mental retardation protein

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

A decade of molecular studies of fragile X syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Fragile X syndrome: the GABAergic system and circuit dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Fragile X syndrome: assessment and treatment implications

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Phosphorylated fragile X mental retardation protein at serine 499, is reduced in cerebellar vermis and superior frontal cortex of subjects with autism: implications for fragile X mental retardation protein-metabotropic glutamate receptor 5 signaling

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Neuregulin1-induced cell migration is impaired in schizophrenia: association with neuregulin1 and catechol-o-methyltransferase gene polymorphisms

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Epistatic and functional interactions of catechol-o-methyltransferase (COMT) and AKT1 on neuregulin1-ErbB signaling in cell models

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Neuregulin 1-induced AKT phosphorylation in monozygotic twins discordant for schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Dysregulation of mTOR signaling in fragile X syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

CGG repeat in the FMR1 gene: size matters

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

Direct Blue 71 staining as a destaining-free alternative loading control method for Western blotting

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0257-Z

21 January 2018

The fragile x mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12031-014-0257-Z

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24563264%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24563264%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54375474&oldid=2212444776"